Potential therapeutic applications of plant toxin-ricin in cancer: challenges and advances

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Nikhil TyagiPrahlad C Ghosh

Abstract

Cancer is one of the most common devastating disease affecting millions of people per year worldwide. To fight against cancer, a number of natural plant compounds have been exploited by researchers to discover novel anti-cancer therapeutics with minimum or no side effects and plants have proved their usefulness in anti-cancer therapy in past few years. Ricin, a cytotoxic plant protein isolated from castor bean seeds, is a ribosome-inactivating protein which destroys the cells by inhibiting proteins synthesis. Ricin presents great potential as anti-cancer agent and exerts its anti-cancer activity by inducing apoptosis in cancer cells. In this review, we summarize the current information on anti-cancer properties of plant toxin ricin, its potential applications in cancer therapy, challenges associated with its use as therapeutic agent and the recent advances made to overcome these challenges. Nanotechnology could open the doors for quick development of ricin-based anti-cancer therapeutics. Conceivably, ricin may serve as a chemotherapeutic agent against cancer by utilizing nanocarriers for its targeted delivery to cancer cells.

References

Feb 1, 1979·FEBS Letters·G J Dimitriadis, T D Butters
Jan 1, 1978·Journal of Supramolecular Structure·G L Nicolson, G Poste
Apr 1, 1977·European Journal of Biochemistry·O Fodstad, S Olsnes
Feb 1, 1988·The Journal of Cell Biology·B van DeursG Griffiths
Oct 1, 1986·Cellular Immunology·O W PressP J Martin
Nov 1, 1988·British Journal of Haematology·F W PreijersP J Capel
Jul 1, 1987·Archives of Biochemistry and Biophysics·H T Wright, J D Robertus
Jul 1, 1973·Toxicon : Official Journal of the International Society on Toxinology·J Y LinT C Tung
Oct 1, 1984·The Journal of Experimental Medicine·V Raso, J Lawrence
May 1, 1996·Human & Experimental Toxicology·J N HughesG D Griffiths
Dec 4, 1998·Biochemistry·A Keppler-HafkemeyerI Pastan
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·R BalunaE S Vitetta
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·M SchmidC Gietl
Aug 17, 2000·Bioscience, Biotechnology, and Biochemistry·N HasegawaT Muramatsu
May 18, 2001·Nature·G I Evan, K H Vousden
Dec 6, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·N G PattrickR Duncan
Nov 20, 2002·Biotechnology Annual Review·Michael A Gosselin, Robert J Lee
Jun 14, 2003·Drug News & Perspectives·V J Ram, S Kumari
Oct 29, 2003·Toxicological Reviews·Michael J LordLynne M Roberts
Feb 13, 2004·The Journal of Biological Chemistry·Yu-Hauh WuJung-Yaw Lin
May 20, 2004·International Journal of Medical Microbiology : IJMM·Kirsten SandvigBo van Deurs
Aug 11, 2004·Toxicon : Official Journal of the International Society on Toxinology·Sjur Olsnes
Feb 3, 2005·Proceedings of the National Academy of Sciences of the United States of America·John S GreenwoodChristine Gietl
Feb 16, 2005·Biochemical Pharmacology·P V Lakshmana RaoR Vijayaraghavan
Nov 10, 2005·JAMA : the Journal of the American Medical Association·Jennifer AudiJohn Osterloh
Oct 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·S M Harley, H Beevers
Oct 10, 2006·The AAPS Journal·Robert J Kreitman
Jul 7, 2007·The AAPS Journal·Vladimir P Torchilin

❮ Previous
Next ❯

Citations

May 26, 2016·Nanomedicine·Esther VazquezAntonio Villaverde
May 24, 2016·Critical Reviews in Oncology/hematology·Nishant Singh, Anuradha Bharara Singh
Dec 22, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Shilpa ChooniedassJeannick Cizeau
Jun 10, 2017·International Journal of Molecular Sciences·Guillaume PoirouxPierre Rougé
May 17, 2019·Chemical Communications : Chem Comm·Chun Hong LiShu Jun Zhen
Jun 9, 2019·Toxins·Letizia PolitoAndrea Bolognesi
Mar 9, 2020·Cancer Chemotherapy and Pharmacology·Parthasaradhireddy TanguturiSuresh Ramakrishna
May 26, 2017·Biomedicines·Letizia PolitoMassimo Bortolotti
Jan 11, 2019·International Journal of Molecular Sciences·Guillaume PoirouxHervé Benoist
Jun 21, 2019·Toxins·Natalia Sowa-RogozińskaMonika Słomińska-Wojewódzka
Dec 4, 2019·Cancer Letters·Maria J PiñaF Javier Arias
Mar 10, 2018·International Journal of Biological Macromolecules·L C Meneguelli de SouzaO L T Machado

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Toxicon : Official Journal of the International Society on Toxinology
M IshiguroM Funatsu
Biochimica Et Biophysica Acta
L BarbieriF Stirpe
© 2021 Meta ULC. All rights reserved